Olanzapine-induced ischemic colitis

Background: Ischemic colitis (IC) is an uncommon adverse event associated with antipsychotic agents, more commonly found with phenothiazine drugs and atypical neuroleptics such as clozapine. The risk of developing ischemic colitis increases when anticholinergic drugs are associated. Case report: We report the case of a 38-year-old woman with a history of schizoaffective disorder who had been on chronic quetiapine for 3 years, and presented to the ER because of diarrhea for 5 days. Four months previously, olanzapine had been added to her psychiatric drug regimen. Physical examination revealed abdominal distension with abdominal tympanic sounds and tenderness. Emergency laboratory tests were notable for increased acute phase reagents. Tomography revealed a concentric thickening of the colonic wall in the transverse, descending and sigmoid segments, with no signs of intestinal perforation. Colonoscopy demonstrated severe mucosal involvement from the sigmoid to the hepatic flexure, with ulcerations and fibrinoid exudate. Biopsies confirmed the diagnosis of ischemic colitis. The only relevant finding in her history was the newly added drug to her baseline regimen. An adverse effect was suspected because of its anticholinergic action at the intestinal level, and the drug was withdrawn. After 6 months of follow-up clinical, laboratory and endoscopic recovery was achieved. Discussion: Antipsychotic medication should be considered as a potential cause of ischemic colitis, particularly atypical antipsychotics such as clozapine and olanzapine; despite being uncommon, this adverse event may result in high morbidity and mortality.

Saved in:
Bibliographic Details
Main Authors: Sáez-González,Esteban, Díaz-Jaime,Francia Carolina, Blázquez-Martínez,María Teresa, del-Val-Antoñana,Adolfo, Ortuño-Cortés,Juan Antonio
Format: Digital revista
Language:English
Published: Sociedad Española de Patología Digestiva 2016
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000800015
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1130-01082016000800015
record_format ojs
spelling oai:scielo:S1130-010820160008000152016-09-26Olanzapine-induced ischemic colitisSáez-González,EstebanDíaz-Jaime,Francia CarolinaBlázquez-Martínez,María Teresadel-Val-Antoñana,AdolfoOrtuño-Cortés,Juan Antonio Ischemic colitis Olanzapine Antipsychotic drugs Background: Ischemic colitis (IC) is an uncommon adverse event associated with antipsychotic agents, more commonly found with phenothiazine drugs and atypical neuroleptics such as clozapine. The risk of developing ischemic colitis increases when anticholinergic drugs are associated. Case report: We report the case of a 38-year-old woman with a history of schizoaffective disorder who had been on chronic quetiapine for 3 years, and presented to the ER because of diarrhea for 5 days. Four months previously, olanzapine had been added to her psychiatric drug regimen. Physical examination revealed abdominal distension with abdominal tympanic sounds and tenderness. Emergency laboratory tests were notable for increased acute phase reagents. Tomography revealed a concentric thickening of the colonic wall in the transverse, descending and sigmoid segments, with no signs of intestinal perforation. Colonoscopy demonstrated severe mucosal involvement from the sigmoid to the hepatic flexure, with ulcerations and fibrinoid exudate. Biopsies confirmed the diagnosis of ischemic colitis. The only relevant finding in her history was the newly added drug to her baseline regimen. An adverse effect was suspected because of its anticholinergic action at the intestinal level, and the drug was withdrawn. After 6 months of follow-up clinical, laboratory and endoscopic recovery was achieved. Discussion: Antipsychotic medication should be considered as a potential cause of ischemic colitis, particularly atypical antipsychotics such as clozapine and olanzapine; despite being uncommon, this adverse event may result in high morbidity and mortality.Sociedad Española de Patología DigestivaRevista Española de Enfermedades Digestivas v.108 n.8 20162016-08-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000800015en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Sáez-González,Esteban
Díaz-Jaime,Francia Carolina
Blázquez-Martínez,María Teresa
del-Val-Antoñana,Adolfo
Ortuño-Cortés,Juan Antonio
spellingShingle Sáez-González,Esteban
Díaz-Jaime,Francia Carolina
Blázquez-Martínez,María Teresa
del-Val-Antoñana,Adolfo
Ortuño-Cortés,Juan Antonio
Olanzapine-induced ischemic colitis
author_facet Sáez-González,Esteban
Díaz-Jaime,Francia Carolina
Blázquez-Martínez,María Teresa
del-Val-Antoñana,Adolfo
Ortuño-Cortés,Juan Antonio
author_sort Sáez-González,Esteban
title Olanzapine-induced ischemic colitis
title_short Olanzapine-induced ischemic colitis
title_full Olanzapine-induced ischemic colitis
title_fullStr Olanzapine-induced ischemic colitis
title_full_unstemmed Olanzapine-induced ischemic colitis
title_sort olanzapine-induced ischemic colitis
description Background: Ischemic colitis (IC) is an uncommon adverse event associated with antipsychotic agents, more commonly found with phenothiazine drugs and atypical neuroleptics such as clozapine. The risk of developing ischemic colitis increases when anticholinergic drugs are associated. Case report: We report the case of a 38-year-old woman with a history of schizoaffective disorder who had been on chronic quetiapine for 3 years, and presented to the ER because of diarrhea for 5 days. Four months previously, olanzapine had been added to her psychiatric drug regimen. Physical examination revealed abdominal distension with abdominal tympanic sounds and tenderness. Emergency laboratory tests were notable for increased acute phase reagents. Tomography revealed a concentric thickening of the colonic wall in the transverse, descending and sigmoid segments, with no signs of intestinal perforation. Colonoscopy demonstrated severe mucosal involvement from the sigmoid to the hepatic flexure, with ulcerations and fibrinoid exudate. Biopsies confirmed the diagnosis of ischemic colitis. The only relevant finding in her history was the newly added drug to her baseline regimen. An adverse effect was suspected because of its anticholinergic action at the intestinal level, and the drug was withdrawn. After 6 months of follow-up clinical, laboratory and endoscopic recovery was achieved. Discussion: Antipsychotic medication should be considered as a potential cause of ischemic colitis, particularly atypical antipsychotics such as clozapine and olanzapine; despite being uncommon, this adverse event may result in high morbidity and mortality.
publisher Sociedad Española de Patología Digestiva
publishDate 2016
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000800015
work_keys_str_mv AT saezgonzalezesteban olanzapineinducedischemiccolitis
AT diazjaimefranciacarolina olanzapineinducedischemiccolitis
AT blazquezmartinezmariateresa olanzapineinducedischemiccolitis
AT delvalantonanaadolfo olanzapineinducedischemiccolitis
AT ortunocortesjuanantonio olanzapineinducedischemiccolitis
_version_ 1755938720427540480